Webinar: Integrating data with Open PHACTS: Private and Public

Jean-Marc Neefs (Janssen) and Luca Bartek (University of Strathclyde) demonstrate how integrating data with the Open PHACTS Discovery Platform helps meet business needs to query combined public and private datasets, as well as supporting further linked data analysis through resources such as Wikidata. Watch webinar video

Webinar: Integrating data with Open PHACTS: Private and Public

Since completion of the Open PHACTS project, we’ve opened up our regular discussions about using Open PHACTS for science to the whole community, with a series of free monthly webinars. Our next webinar will be about how integrating private data and public Wikidata with Open PHACTS opens up new business question opportunities. Register now for our webinar Read more about Webinar: Integrating data with Open PHACTS: Private and Public[…]

Webinar: Target Validation Protocols

Now that the Open PHACTS project is complete, we’re opening our regular discussions about using Open PHACTS for science up to the whole community, with a series of free monthly webinars. Our next webinar will be about how the Open PHACTS Discovery Platform can be used for in silico target validation. Register now for our Target Read more about Webinar: Target Validation Protocols[…]

Conference: 251st ACS National Meeting & Exposition

251st ACS National Meeting & Exposition, San Diego, USA Herman van Vlijmen (Janssen) gave a presentation: Open PHACTS: Semantic interoperability for drug discovery Valery Tkachenko (Royal Society of Chemistry) gave a presentation: Implementing chemistry platform for Open PHACTS: Lessons learned Anna Gaulton (EMBL-EBI) gave a presentation: Representation of drug discovery knowledge in the ChEMBL and SureChEMBL databases

Press Release: Open PHACTS Foundation announces first three members: GSK, Janssen and Roche

(PDFCambridge, UK – The not-for-profit Open PHACTS Foundation announced its first three members today – GlaxoSmithKline, Janssen and Roche – who will steer the future of the successor organisation to the Innovative Medicines Initiative (IMI)- funded Open PHACTS project.

The commitment by these global pharmaceutical industry members signifies a major step in ensuring the sustainability of infrastructure developed during the Open PHACTS project.

[…]

2nd Open PHACTS Pipeline Pilot Hackathon held

On 6 March, 2014, the 2nd Open PHACTS Pipeline Pilot Hackathon took place on the Merck campus in Darmstadt, Germany. Attendees from eight different industrial and academic institutions worked on the new version 2.0 of the Open PHACTS component collection which was provided by Accelrys through financial support by Janssen Pharmaceutica. Presenters explained and demonstrated how new Read more about 2nd Open PHACTS Pipeline Pilot Hackathon held[…]

Press Release: Five new partners join Open PHACTS

(PDFThe Open PHACTS consortium is pleased to announce that ConnectedDiscovery, the European Bioinformatics Institute, Janssen, the Netherlands Bioinformatics Centre, and the Swiss Institute of Bioinformatics have joined the project as new consortium members.

The addition of these partners – bringing together respected drug discovery and bioinformatics expertise from academic institutions, a small start-up, and an EFPIA company – demonstrates the progress and promise of this project as it nears its halfway point.

[…]

Second Open PHACTS Workshop held

On 16-17 April 2012 the 2nd Open PHACTS Community Workshop was held at the RSC‘s Chemistry Centre, Burlington House, London. This workshop provided an understanding of the scientific and technical background to Open PHACTS, featured the current status, and gave the opportunity to discuss particular issues around data integration, licensing and sustainability with new consortium members, Read more about Second Open PHACTS Workshop held[…]